Wall Street slips as oil prices keep dropping

U.S. equities were mixed as the S&P 500 slipped 0.2% and the Dow fell 302 points (0.6%) while the Nasdaq rose 0.2%, and the 10-year Treasury yield eased to 4.14% after conflicting economic data — unemployment hit its highest level since 2021 even as payrolls topped estimates and retail revenue strength surprised to the upside. A preliminary S&P Global report showed selling prices climbing at one of the fastest rates since mid-2022 while overall business activity slowed to its weakest since June, underscoring persistent price pressures ahead of Thursday’s CPI print and leaving the timing of Fed rate cuts uncertain. Commodity and sector moves accentuated the market tone: U.S. crude dropped to $55.27/barrel (lowest since 2021), weighing on oil names (APA -5.2%, Marathon -4.7%, Halliburton -4.3%), AI-related stocks were mixed, Pfizer fell on a below-expectations 2026 profit forecast, and major Asian and European indexes also declined ahead of key central bank actions.

Analysis

U.S. equities traded mixed as the S&P 500 slipped 0.2% to 6,800.26 and the Dow fell 302.30 points to 48,114.26 while the Nasdaq rose 54.05 to 23,111.46, and the 10-year Treasury yield eased to 4.14% from 4.18%. Economic data were contradictory: the unemployment rate moved to its worst level since 2021 even as payrolls exceeded expectations and a separate retail revenue series showed stronger-than-expected October growth.

Preliminary S&P Global data signaled rising input and selling prices—one of the fastest increases since mid-2022—while overall business activity slowed to its weakest since June, and the report highlighted tariff-driven pass-through into services. Those price-pressure signals, together with the upcoming CPI print on Thursday, leave the timing and scope of expected Fed rate cuts in 2026 highly uncertain.

Sector moves reflected these macro cross-currents: crude fell to $55.27 a barrel (Brent $58.92), pressuring oil names (APA -5.2%, Marathon/MPC -4.7%, Halliburton/HAL -4.3%), AI-related names were mixed with Oracle +2% and Broadcom +0.4% after recent earnings beats while CoreWeave fell 3.9%, and Pfizer dropped 3.4% after providing 2026 profit guidance below some analysts' expectations. International markets weakened (Nikkei -1.6%, Kospi -2.2%, Hong Kong -1.5%, Shanghai -1.1%) ahead of central-bank moves, underscoring cross-border rate and growth risks.

Key Decisions for Investors

• Treat Thursday's CPI release as a near-term market catalyst and prepare to reduce duration and equity beta if CPI prints materially hotter than expected,
• Trim or underweight U.S. exploration and oil-service exposure after crude slid to $55.27 and oil names dropped materially; consider re-entry only if supply/demand indicators improve,
• Bias toward AI incumbents with demonstrated profitability and recent earnings beats (e.g., Oracle, Broadcom) versus capital‑intensive AI infra renters like CoreWeave,
• Reassess positions in large-cap healthcare with guidance risk after Pfizer's weaker 2026 profit outlook and consider waiting for updated company-level catalysts before adding,
• Monitor global rate signals (BoJ guidance and U.S. 10‑year moves) for potential FX and cyclicality impacts and adjust exposure to rate-sensitive sectors accordingly